Medical University of Vienna clinical trial pipeline

12 trials changed in the last 30 days: 0 stopped, 3 with notable changes, 9 with minor changes only.

1. Notable

   MILLENNIAL · Edge-to-edge Mitral Valve Repair in ATTR-CM

   Recruitment opened

   Also in this update: Primary endpoint(s) modified; Trial sites expanded: 0 → 10 locations

   Medical University of Vienna·Not applicable· NCT06075823· Registry history of NCT06075823 on ClinicalTrials.gov (opens the registry)

   Oct 16, 2026

2. Notable

   MethMax · MAXimising the METHotrexate Therapy Potential · Active…MethMax · MAXimising the METHotrexate Therapy Potential · Active Rheumatoid Arthritis

   Primary and study completion pushed from Sep 30, 2026 to Jun 7, 2027

   Medical University of Vienna·Phase 4· NCT06649136· Registry history of NCT06649136 on ClinicalTrials.gov (opens the registry)

   Oct 6, 2026

3. Notable

   Validation of Continuous Transcutaneous Carbon Dioxide Monitoring…Validation of Continuous Transcutaneous Carbon Dioxide Monitoring in VA-ECMO Patients

   Primary and study completion dates pushed to Dec 31, 2026

   Medical University of Vienna·Not specified· NCT04445909· Registry history of NCT04445909 on ClinicalTrials.gov (opens the registry)

   Oct 8, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.